[5'-O-DMTr-2'-dG(iBu)](pCyEt)[2'-dG(iBu)](pCyEt)[2'-dG(iBu)-3'-CE-Phosphoramidite]
[5'-O-DMTr-2'-dG(iBu)](pCyEt)[2'-dG(iBu)](pCyEt)[2'-dG(iBu)-3'-CE-Phosphoramidite] - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Related Products
Specifications
Specifications
-
Catalog No.OP-234
-
SMILESO=C1C(N=CN2[C@H]3C[C@H](OP(OC[C@H]4O[C@@H](N(C=N5)C6=C5C(NC(NC(C(C)C)=O)=N6)=O)C[C@@H]4OP(N(C(C)C)C(C)C)OCCC#N)(OCCC#N)=O)[C@@H](COP(O[C@H]7C[C@H](N(C=N8)C9=C8C(NC(NC(C(C)C)=O)=N9)=O)O[C@@H]7COC(C%10=CC=CC=C%10)(C%11=CC=C(OC)C=C%11)C%12=CC=C(OC)C=C%12)(OCCC#N)=O)O3)=C2N=C(NC(C(C)C)=O)N1
-
Molecular FormulaC78H96N19O22P3
-
Molecular Weight1744.66
-
AppearanceWhite, off-white to light yellow powder, free from visible foreign matter
-
PurityUPLC≥98%
-
Storage Condition-20℃
Documentation
Documentation
-
Catalog No.OP-234
-
SMILESO=C1C(N=CN2[C@H]3C[C@H](OP(OC[C@H]4O[C@@H](N(C=N5)C6=C5C(NC(NC(C(C)C)=O)=N6)=O)C[C@@H]4OP(N(C(C)C)C(C)C)OCCC#N)(OCCC#N)=O)[C@@H](COP(O[C@H]7C[C@H](N(C=N8)C9=C8C(NC(NC(C(C)C)=O)=N9)=O)O[C@@H]7COC(C%10=CC=CC=C%10)(C%11=CC=C(OC)C=C%11)C%12=CC=C(OC)C=C%12)(OCCC#N)=O)O3)=C2N=C(NC(C(C)C)=O)N1
-
Molecular FormulaC78H96N19O22P3
-
Molecular Weight1744.66
-
AppearanceWhite, off-white to light yellow powder, free from visible foreign matter
-
PurityUPLC≥98%
-
Storage Condition-20℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
[2'-dG(iBu)](pCyEt)[2'-dG(iBu)-3'-CE-Phosphoramidite]](http://shop.hongene.com/cdn/shop/files/OP-234_410a9222-e3a4-48f5-b18d-8c2acb431b02.jpg?v=1748588813&width=1214)